TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARQT

Arcutis Biotherapeutics Inc

Healthcare · Biotechnology

25.40$ -4.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ARQT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
+1,517.1% +229.7% +91.3%
+133.3% +67.7% -1.2% +561.4% +283.6% +91.8%
+1,762.9% +224.8% +91.3%
+425.9% +103.6% +215.7% +26.2% +25.3% -39.4% -30.9% +0.8%
+158.3% +268.2% +222.8% +185.8% +100.3% +42.1% +28.2% +23.4%
+380.6% +117.6% +217.2% +51.6% +47.5% -2.9% +3.4% +15.0%
+3,347.6% +89.8% -8.6% -55.5%
-464.3% -68.3% -79.2% +81.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?